Evidence map›Paper›PMID 37604632›Full record

ArticleBMJ open2023

Implementation of the HepC

Juliana Reyes-Urueña, Francisco Costell-González, Laia Egea-Cortés, Hakima Ouaarab, Veronica Saludes, Maria Buti, Xavier Majó I Roca, Joan Colom, Jordi Gómez I Prat, Jordi Casabona and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Juliana Reyes-Urueña *Centre for Epidemiological Studies on STD/HIV/SIDA of Catalonia, Public Health Agency of Catalonia, Badalona, Spain juliana.reyes81@gmail.com.ORCID 0000-0002-3122-6518
Francisco Costell-González *Centre for Epidemiological Studies on STD/HIV/SIDA of Catalonia, Public Health Agency of Catalonia, Badalona, Spain.
Laia Egea-CortésCentre for Epidemiological Studies on STD/HIV/SIDA of Catalonia, Public Health Agency of Catalonia, Badalona, Spain.
Hakima OuaarabUnitat de Salut Internacional Vall Hebrón-Drassanes, Hospital Universitario Vall Hebrón, Barcelona, Spain.
Veronica SaludesMicrobiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Maria ButiServicio de Hepatología, Hospital Universitario Vall Hebrón, Barcelona, Spain.
Xavier Majó I RocaPrograma de prevenció, control i atenció al virus d'immunodeficiència humana (VIH), les infeccions de transmissió sexual (ITS) i les hepatitis víriques (HV) (PCVIHV), Public Health Agency of Catalonia, Barcelona, Spain.
Joan ColomPrograma de prevenció, control i atenció al virus d'immunodeficiència humana (VIH), les infeccions de transmissió sexual (ITS) i les hepatitis víriques (HV) (PCVIHV), Public Health Agency of Catalonia, Barcelona, Spain.
Jordi Gómez I PratUnitat de Salut Internacional Vall Hebrón-Drassanes, Hospital Universitario Vall Hebrón, Barcelona, Spain.
Jordi CasabonaCentre for Epidemiological Studies on STD/HIV/SIDA of Catalonia, Public Health Agency of Catalonia, Badalona, Spain.
Elisa MartroMicrobiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
HepClink Study Group
Generalitat de Catalunya · ESVall d'Hebron Hospital Universitari · ESAgencia de Salud Pública de Barcelona · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo perform a budget impact analysis of the HepC

methodsWe estimated the population of adult Pakistani migrants registered at the primary care centres in Catalonia by means of the Information System for the Development of Research in Primary Care (n=37 972 in 2019, Barcelona health area). This cohort was followed for a time period of 10 years after HCV diagnosis (2019-2028). The statistical significance of the differences observed in the anti-HCV positivity rate between screened and non-screened was confirmed (α=0.05). The budget impact was calculated from the perspective of the Catalan Department of Health. Sensitivity analyses included different levels of participation in HepC

resultsThe HepC

conclusionsScaling up the HepC

Indexed as

Hepatitis CTransients and MigrantsAdultHepacivirusHumansPakistanSpainViremiaEpidemiologyHealth policyPublic health

Identifiers

PMID37604632
PMCPMC10445371
OpenAlexW4386034872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.